Bosh sahifa4502 • TYO
add
Takeda Pharmaceutical Co Ltd
Yopilish kursi
4 121,00 ¥
Kunlik diapazon
4 109,00 ¥ - 4 137,00 ¥
Yillik diapazon
3 852,00 ¥ - 4 494,00 ¥
Bozor kapitalizatsiyasi
6,54 trln JPY
Oʻrtacha hajm
3,67 mln
Narx/foyda
22,61
Dividend daromadliligi
4,67%
Asosiy maydon
TYO
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (JPY) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,18 trln | 12,75% |
Joriy xarajat | 540,19 mlrd | -10,33% |
Sof foyda | 92,05 mlrd | 291,64% |
Sof foyda marjasi | 7,83 | 270,22% |
Har bir ulushga tushum | — | — |
EBITDA | 433,99 mlrd | 55,12% |
Amaldagi soliq stavkasi | 22,84% | — |
Balans
Jami aktivlari
Jami passivlari
| (JPY) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 859,02 mlrd | 170,09% |
Jami aktivlari | 14,57 trln | -2,01% |
Jami passivlari | 7,65 trln | -1,92% |
Umumiy kapital | 6,92 trln | — |
Tarqatilgan aksiyalar | 1,59 mlrd | — |
Narxi/balansdagi bahosi | 0,94 | — |
Aktivlardan daromad | 3,92% | — |
Kapitaldan daromad | 4,57% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (JPY) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 92,05 mlrd | 291,64% |
Operatsiyalardan naqd pul | 280,96 mlrd | 41,25% |
Sarmoyadan naqd pul | -75,13 mlrd | -24,02% |
Moliyadan naqd pul | -110,04 mlrd | 21,76% |
Naqd pulning sof oʻzgarishi | 54,00 mlrd | 3 129,84% |
Boʻsh pul | 97,22 mlrd | -39,87% |
Haqida
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
Tashkil etilgan
12-iyn, 1781
Sayt
Xodimlar soni
49 281
